编辑|于靖
6月23日,中国生物制药发布公告,拟以总价1.61亿美元(约10.8亿人民币)或每股7.12美元的价格,收购在美国Nasdaq上市的F-star Therapeutics(以下简称F-star)。这一消息立刻在业内引起轰动,F-star股价也应声大涨,当日涨幅近60%,每股报收6.36美元(图1)。
查看全文
chuminhua2020-07-31 00:13
7/29,F-star Therapeutics将与Spring Bank Pharmaceuticals$Spring Bank制药(SBPH)$ 合并,以在纳斯达克上市,支持其双特异性抗体产品线的开发。 几个月前Spring Bank的乙肝2b期试验失败,股价暴跌,该公司转而开发STING激动剂SB 11285。F-star因与大药企开展交易而闻名,最近几年已经聚焦于内部...查看全文
chuminhua2020-01-30 22:54
1/29,Spring Bank Pharmaceuticals$Spring Bank制药(SBPH)$ 的情况越来越糟。该公司研究人员称,一名患者在inarigivir治疗乙肝的IIb期研究中死亡后,他们正在将工作重点转移到STING上面。inarigivir的安全性问题在于潜在的肝细胞功能障碍,和ALT升高。研究失败导致该公司股价暴跌。查看全文
$Spring Bank Pharmaceuticals, Inc.(SBPH)$ 8-K - Current report Filed: 2018-03-05 AccNo: 0001564590-18-004381 Size: 50 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers...
$Spring Bank Pharmaceuticals, Inc.(SBPH)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2018-02-20 AccNo: 0001564590-18-002474 Size: 8 MB 网页链接
$Spring Bank Pharmaceuticals, Inc. Common Stock(SBPH)$ 美东时间 2016-06-02 14:30 Spring Bank Pharmaceuticals Inc at Marcum MicroCap Conference 网页链接
$Spring Bank Pharmaceuticals, Inc. Common Stock(SBPH)$ 美东时间 2016-06-02 14:30 Spring Bank Pharmaceuticals Inc at Marcum MicroCap Conference 网页链接
$Spring Bank Pharmaceuticals, Inc. Common Stock(SBPH)$ 美东时间 2016-06-21 10:30 Spring Bank Pharmaceuticals Inc at JMP Securities Life Sciences Conference 网页链接